Novel dielectric behavior of a linear increase in ionic conductivity prior to melt temperature was observed for active pharmaceutical ingredients (APIs), organic chemicals, amino acids, and carbohydrates. Though, there are solids like polyolefins and long chain organic compounds (tetracosane, pentacosane) which do not exhibit this premelt behavior (i.e., the temperature where the onset of increase in ionic conductivity to melt temperature). We have discovered novel electrical conductivity properties and other physical analytical variations which can lead to unique synthetic routes of certain chemical entities. The above-mentioned unique variations are not related to solid–solid transitions which are quite often observed in pharmaceutical crystalline solids. These new properties are related to amorphous crystalline behavior of a solid. We have also studied the effect of various experimental variables: such as amount of mass tested, applied frequency at a given electric field and heating rate, which results in varying the onset temperature of the increase in ionic conductivity. Melting of the solids was correlated using differential scanning calorimetry (DSC). Activation energies for all the solids were measured in the premelt region using an Arrhenius plot at a specific frequency since we observed changes in the conductivity with frequency. This study focused on frequencies 0.1 to 10 Hz, since the conductivity at these frequencies related to surface analysis. This new physical properties are leading to new electro synthetic procedures to modify or prepare chemicals.
1. Riga, A, Alexander, KS. Electrical conductivity analysis/dielectric analysis differentiate physical chemical properties of drugs and excipients. Am Pharm Rev. 2005;8: 6 45–51.
2. Hilfiker, R, Blatter, F, von Raumer, M. Relevance of solid state properties for pharmaceutical products Hilfiker, R, eds. Polymorphism in pharmaceutical industry. Weinheim: Wiley-Vch Verlag Gmbh; 2006 1–20. .
3. Amidon, GL, Lennernäs, H, Shah, VP, Crison, JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12:413–420. .
4. Yu, LX, Amidon, GL, Polli, JE, Zhao, H, Mehta, M, Conner, DP, Shah, VP, Lesko, LJ, Chen, M-L, Lee, VHL, Hussain, AS. Biopharmaceutics classification system: the scientific basis for biowaiver extension. Pharm Res. 2002;19:921–925. .
5. Giron, D, Mutz, M. Solid state of pharmaceutical compounds impact of ICH Q6 guideline on industrial development. J Therm Anal Calorim. 2004;77:709–747. .
6. Wesolowski, M. Thermo analytical methods in pharmaceutical technology. J Therm Anal Calorim. 1992;38:2239–2245. .
7. Fagegaltier, N, Lamure, A, Lacabanne, C, Caron, A, Mifsud, H, Bauer, M. Thermal analysis of amorphous phase in a pharmaceutical drug. J Therm Anal Calorim. 1997;48:459–464. .
8. Riga AT . Distinguishing amorphous polymer blends from copolymers by wide angle X-ray diffraction. Polymer Eng Sci. 1978;18:366; ibid 18, no.15, 1144–1147.
9. Mesaros, DV, Oyumi, Y, Brill, TB, Dybowski, C. NMR investigation of the premelt phase of hexahydro-1,3,5-trinitroso-s-triazine. J Phys Chem. 1986;90: 9 1970–1973. .
10. Matthews, ME, Atkinson, I, Lubaina Presswala, Najjar, O, Nadine Gerhardstein, Wei, R, Elizabeth Rye, Riga, AT. Dielectric classification of d and l amino acids by thermal analytical methods. J Therm Anal Calorim. 2008;93:281–287. .